A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery
The purpose of this study is to find out what patients consider when deciding whether or not to receive adjuvant treatment, and how patients feel about their decision after one year.
Cutaneous Melanoma
BEHAVIORAL: Demographics Questionnaire|BEHAVIORAL: Adjuvant Treatment Beliefs Scale10|BEHAVIORAL: Functional Assessment of Cancer Therapy - Melanoma (FACT-M)11|BEHAVIORAL: Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction - General (FACIT-TS-G)13|BEHAVIORAL: Decisional Regret14|BEHAVIORAL: Clinician Preference for Treatment
self-reported factors patients consider in deciding whether or not to undergo adjuvant therapy, Factors considered are gleaned from the Acceptance/Declination Survey, 1 year
self-reported quality of life, as captured by FACT-M, as well as treatment satisfaction. Functional Assessment of Cancer Therapy - Melanoma (FACT-M)11 - FACT-M is a 51- item patient-self report measure for the assessment of quality of life (QOL) in patients with American Joint Committee on Cancer stages I through IV melanoma.The FACT-M incorporates a recall period of 7-days and a five-point Likert-type scale (i.e., 0 = Not at all, 1 = A little bit, 2 = Somewhat, 3 = Quite a bit, 4 = Very much)., 1 year
The purpose of this study is to find out what patients consider when deciding whether or not to receive adjuvant treatment, and how patients feel about their decision after one year.